Celularity Inc. (CELU)
NASDAQ · Healthcare
Celularity Inc. EBITDA 2020–2025
Celularity Inc. annual/quarterly ebitda history and growth rate from 2020 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Celularity Inc. ebitda for the quarter ending March 31, 2025 was -8.7 M, a 65.75% increase year-over-year.
- Celularity Inc. ebitda for the twelve months ending March 31, 2025 was -32.5 M, a 84.02% decrease year-over-year.
- Celularity Inc. annual ebitda for 2025 was -54.0 M, a 77.46% increase from 2024.
- Celularity Inc. annual ebitda for 2024 was -30.4 M, a 83.36% decrease from 2023.
- Celularity Inc. annual ebitda for 2023 was -183.0 M, a 1031.92% increase from 2022.
- Celularity Inc. annual ebitda for 2022 was -16.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Celularity Inc. EBITDA — FAQ
Celularity Inc. (CELU) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CELU's ebitda history?
The chart and table above show Celularity Inc.'s ebitda by year and by quarter, including the growth rate.